Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
11/2001
11/22/2001WO2001087338A1 Immunomodulatory human mhc class ii antigen-binding polypeptides
11/22/2001WO2001087330A2 Compositions and methods for achieving immune suppression
11/22/2001WO2001087303A1 Aqueous liquid preparation
11/22/2001WO2001087299A1 Aralkyl ester soft drugs
11/22/2001WO2001087286A2 Antisense enzyme inhibitors for improving pharmacokinetics of a drug
11/22/2001WO2001087267A1 Protein matrix materials, devices and methods of making and using thereof
11/22/2001WO2001087263A2 Delivery systems for treatment of vascular disease
11/22/2001WO2001087234A2 Treatment of autoimmune, proliferative and inflammatory diseases with compositions of non-ionic copolymers
11/22/2001WO2001060312A8 Device for calculating elixir doses appropriate for a patient's weight
11/22/2001WO2001055333A8 Methods and materials relating to transforming growth factor alpha-like polypeptides and polynucleotides
11/22/2001WO2001047559A9 Patches for external use
11/22/2001WO2001046128A3 Tryptase inhibitors
11/22/2001WO2001042246A3 PYRROLO[2,3-d]PYRIMIDINE COMPOUNDS
11/22/2001WO2001035995A3 Tr3-specific binding agents and methods for their use
11/22/2001WO2001034805A3 Human vanilloid receptor gene
11/22/2001WO2001030781A3 INHIBITORS OF αLβ2 MEDIATED CELL ADHESION
11/22/2001WO2001027146A3 Chemokine receptor
11/22/2001US20010044538 Mitogen-activated protein (MAP) kinase; treating inflammatory diseases; compounds such as 3-(4-fluorophenyl)-1-hydroxy-2-(pyridin-4-yl)-1H-pyrrolo(3,2-b)pyridine
11/22/2001US20010044523 Ligand (ACT-4-L) to a receptor on the surface of activated CD4+ T-cells
11/22/2001US20010044522 Polypeptides, antibodies against them and nucleic acids encoding them; detecting activated CD4+ T-cells to diagnose a disease or condition of the immune system; screening for immunosuppressants
11/22/2001US20010044451 Tyrosine kinase inhibitors
11/22/2001US20010044442 Dimethoxy quinazolines for treating diabetes
11/22/2001US20010044440 Modulators of p38 MAP kinase
11/22/2001US20010043915 Method for administering a cytokine to the central nervous system and the lymphatic system
11/22/2001DE10023492A1 New 2-(((hetero)aryl-alkyl)-amino)-aza-benzamide derivatives, are VEGF receptor, KDR kinase and FLT kinase inhibitors useful e.g. for treating tumors, psoriasis, arthritis or renal or ophthalmological diseases
11/22/2001DE10023484A1 New 2-((cycloalkyl- or heterocyclyl-alkyl)-amino)-benzamide derivatives, are VEGF receptor, KDR kinase and FLT kinase inhibitors useful e.g. for treating tumors, psoriasis, arthritis or renal or ophthalmological diseases
11/22/2001DE10020667A1 Neue Benzoxazin- und Benzothiazin-Derivate und deren Verwendung in Arzneimitteln New benzoxazine and benzothiazine derivatives and their use in medicaments
11/22/2001DE10018221A1 Treating disorders of the teeth, gums or jawbones using growth hormones, preferably human growth hormone or dehydroepiandrosterone, useful e.g. for treating paradontosis or healing jaw operation wounds
11/22/2001CA2781858A1 Modulators of tnf-.alpha. signaling
11/22/2001CA2410077A1 Cyclohexyl derivatives and their use as therapeutic agents
11/22/2001CA2409740A1 Novel aryl, alkenyl, and alkynyl 4-dedimethylaminotetracycline desrivatives
11/22/2001CA2409225A1 Tricyclic pyrazole derivatives
11/22/2001CA2409068A1 Novel dual oxidases as mitogenic and endocrine regulators
11/22/2001CA2409035A1 Hydroxamic acid derivatives
11/22/2001CA2408849A1 Cyclohexane derivatives and their use as therapeutic agents
11/22/2001CA2408842A1 Method for treating retinal degeneration with purinergic receptor agonists
11/22/2001CA2408729A1 Delivery systems for treatment of vascular disease
11/22/2001CA2408719A1 Antiproliferative drug and delivery device
11/22/2001CA2408691A1 Compositions and methods for achieving immune suppression
11/22/2001CA2408617A1 Methods and compositions of matter concerning april/g70, bcma, blys/agp-3, and taci
11/22/2001CA2408608A1 Antiinflammatory drug and delivery device
11/22/2001CA2408513A1 Immunomodulatory human mhc class ii antigen-binding polypeptides
11/22/2001CA2408408A1 Modulators of tnf- alpha signaling
11/22/2001CA2408373A1 Therapeutic approaches to diseases by suppression of the nurr subfamily of nuclear transcription factors
11/22/2001CA2407469A1 Combination therapy using cox-2 selective inhibitor and thromboxane inhibitor and compositions therefor
11/22/2001CA2407258A1 Pharmaceutically active piperidine derivatives, in particular as modulators of chemokine receptor activity
11/22/2001CA2407099A1 Aralkyl ester soft drugs
11/22/2001CA2406013A1 Treatment of autoimmune, proliferative and inflammatory diseases with compositions of non-ionic copolymers
11/22/2001CA2348243A1 Herbal chinese joint complex
11/21/2001EP1156054A1 Drugs containing phosphoric acid derivatives as the active ingredient
11/21/2001EP1156050A2 Substituted tricyclics useful in sPLA2 induced diseases
11/21/2001EP1156049A1 Substituted heterocyclic compounds, their process of preparation and pharmaceutical compositions containing them
11/21/2001EP1156040A1 2,4-dioxo-5-arylidenimino-1,3-pyrimidines
11/21/2001EP1156039A1 Pyridazin-3-one derivatives and medicines containing the same
11/21/2001EP1155025A1 Platinum (ii) compounds
11/21/2001EP1155019A1 Substituted porphyrins
11/21/2001EP1155013A1 Heterocyclic benzenesulphonamide compounds as bradykinine antagonists
11/21/2001EP1155003A1 Novel guanidine derivatives as inhibitors of cell adhesion
11/21/2001EP1155000A1 2-aminopyridines containing fused ring substituents
11/21/2001EP1154999A1 Nitroxyderivatives having antiinflammatory, analgesic and antithrombotic activity
11/21/2001EP1154993A1 Thioamide derivatives
11/21/2001EP1154988A1 Mevinolin derivatives
11/21/2001EP1154987A1 Phenylalaninol derivatives
11/21/2001EP1154803A1 Immobilized labeling compounds and methods
11/21/2001EP1154774A1 Quinazoline derivatives as angiogenesis inhibitors
11/21/2001EP1154769A1 A novel anti-angiogenic agent comprising at least one kringle region and an upstream pre-activation domain of plasminogen
11/21/2001EP1154767A1 Substituted stilbene compounds with vascular damaging activity
11/21/2001EP1154764A1 Epoxide hydrolase complexes and methods therewith
11/21/2001EP0952974B1 Biphenyl derivatives substituted by an aromatic or heteroaromatic radical and pharmaceutical and cosmetic compositions containing same
11/21/2001EP0914319B1 Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists
11/21/2001EP0873340B1 Heterocyclic substituted cyclopentane compounds
11/21/2001EP0784622B1 Naphthyridinone derivatives
11/21/2001CN1323346A TPL-2/COT kinase and methods of use
11/21/2001CN1323314A Inhibitors of caspases
11/21/2001CN1323310A Photocyclized rapamycins
11/21/2001CN1323309A Phenyl yanthine derivatives
11/21/2001CN1323308A New compounds
11/21/2001CN1323302A N-cimidazolylalkyl) substituted cyclic amines as histamine-H3 agonists or antagonists
11/21/2001CN1323301A Diarylbenzopyran derivatives as cyclooxygenase-2 inhibitors
11/21/2001CN1323295A AZA-bicycles which modulate the inhibition of cell adhesion
11/21/2001CN1323291A Diaminopropionic acid derivatives
11/21/2001CN1323225A Polymer conjugates of interferon beta-1a and their uses
11/21/2001CN1323216A Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions
11/21/2001CN1323213A Blood-brain barrier therapeutics
11/21/2001CN1323211A New pharmaceutical uses for NOS inhibitors
11/21/2001CN1323209A Use of piperidines and/or piperazines as inhibitors of p38-alpha kinase
11/21/2001CN1323203A FC receptor modulators and uses thereof
11/21/2001CN1323200A New oral formulation for 5-HT4 agonists or antagonists
11/21/2001CN1322719A MYT1 kinase inhibitor
11/21/2001CN1322556A Chinese medicine preparation for treating rheumatism and rheumatoid disease
11/21/2001CN1322535A Recipe and preparation of hot compressing Chinese herbal medicine
11/21/2001CN1322523A External-use Mayroxicam gel agent and its preparation
11/21/2001CN1075059C Colchicine derivatives and its therapeutical use
11/21/2001CN1074932C Ophthalmic compositions
11/21/2001CN1074918C Use of Ropivacaine in the manufacture of a pharmaceutical with analgetic effect with minimal motion blockade
11/21/2001CN1074898C Ionene polymers, producing process, its intermediate and use
11/20/2001US6320037 IBD-associated microbial nucleic acid molecules
11/20/2001US6319938 Prophylactic or therapeutic drug for renal diseases
11/20/2001US6319922 Propanoic acid derivatives
11/20/2001US6319921 Aromatic heterocyclic compound as antiinflammatory agents
1 ... 974 975 976 977 978 979 980 981 982 983 984 985 986 987 988 989 990 991 992 993 994 ... 1272